Verition Fund Management
HZNP

Verition Fund Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Verition Fund Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-367,671
Closed -$42.5M – 2825
2023
Q3 		$42.5M Buy
367,671
+7,477
+2% +$803K 0.5% 23
2023
Q2 		$37M Sell
360,194
-525,002
-59% -$55.4M 0.49% 27
2023
Q1 		$96.6M Buy
885,196
+479,372
+118% +$53M 1.34% 2
2022
Q4 		$46.2M Buy
405,824
+310,321
+325% +$25.8M 0.72% 13
2022
Q3 		$5.91M Buy
95,503
+85,920
+897% +$6M 0.07% 360
2022
Q2 		$764K Sell
9,583
-3,381
-26% -$320K 0.02% 1179
2022
Q1 		$1.36M Buy
12,964
+37
+0.3% +$3.61K 0.02% 1261
2021
Q4 		$1.39M Buy
+12,927
New +$1.41M 0.01% 1093
2020
Q4 		– Sell
-5,231
Closed -$406K – 1550
2020
Q3 		$406K Buy
+5,231
New +$360K 0.01% 658
2015
Q3 		– Sell
-15,246
Closed -$530K – 806
2015
Q2 		$530K Buy
+15,246
New +$465K 0.09% 176
2014
Q4 		– Sell
-44,343
Closed -$545K – 747
2014
Q3 		$545K Buy
+44,343
New +$515K 0.08% 216
2014
Q1 		– Sell
-11,987
Closed -$91K – 694
2013
Q4 		$91K Buy
+11,987
New +$64.6K 0.02% 453

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Verition Fund Management's HZNP Position: Q4 2023 in Review

Verition Fund Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 367,671 shares — an estimated $42.5M sold.

Verition Fund Management first reported a position in HZNP in Q4 2013 and held it in 12 quarters. The position peaked at $96.6M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Verition Fund Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Verition Fund Management sold 367,671 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $42.5M.
  • Verition Fund Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 12 quarters.
  • Verition Fund Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $96.6M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Verition Fund Management's 13F filing for Q4 2023, filed 14 Feb 2024.